NEXGEL, Inc. (NASDAQ:NXGL – Get Free Report) saw a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 19,400 shares, an increase of 26.0% from the February 29th total of 15,400 shares. Currently, 0.4% of the shares of the company are sold short. Based on […]
NEXGEL, Inc. (NASDAQ:NXGL – Get Free Report) saw a significant increase in short interest in February. As of February 29th, there was short interest totalling 15,400 shares, an increase of 208.0% from the February 14th total of 5,000 shares. Based on an average trading volume of 18,600 shares, the short-interest ratio is currently 0.8 days. […]
NEXGEL (NASDAQ:NXGL – Get Free Report) and Sigyn Therapeutics (OTCMKTS:SIGY – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, analyst recommendations and earnings. Earnings and Valuation This table compares NEXGEL and […]
NEXGEL, Inc. (NASDAQ:NXGL – Get Free Report) was the target of a large decrease in short interest in the month of December. As of December 31st, there was short interest totalling 4,300 shares, a decrease of 46.9% from the December 15th total of 8,100 shares. Approximately 0.1% of the shares of the company are short […]
NEXGEL, Inc. (NASDAQ:NXGL) Q3 2023 Earnings Call Transcript November 17, 2023 Operator: Good afternoon. I will be your conference operator today. At this time, I would like to welcome everyone to NEXGEL’s Third Quarter 2023 Earnings Conference Call. I will now turn the call over to Valter Pinto, Managing Director of KCSA Strategic Communications, for […]